Related Experiment Video
Updated: May 17, 2026
07:13
Orienteering as a Tool for Cognitive Research: An Implementation Guide
Published on: November 29, 2024
Physical activity, brain plasticity, and Alzheimer's disease
Kirk I Erickson1, Andrea M Weinstein, Oscar L Lopez
1Department of Psychology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. kiericks@pitt.edu
Archives of Medical Research
|October 23, 2012
Summary
Regular physical activity is linked to a reduced risk of dementia and Alzheimer's disease. Exercise also increases brain volume in key areas, potentially improving memory and cognitive function.
Area of Science:
- Neuroscience
- Public Health
- Gerontology
Background:
- Alzheimer's disease (AD) poses a significant global health challenge.
- Age-related cognitive decline impacts millions worldwide.
- Understanding modifiable risk factors like physical activity is crucial.
Purpose of the Study:
- To review evidence on the association between physical activity and brain health.
- To examine the impact of physical activity on brain volume, function, and AD risk.
- To provide recommendations for future research.
Main Methods:
- Systematic review of epidemiological, cross-sectional, and interventional studies.
- Analysis of neuroimaging data from randomized controlled trials.
- Examination of longitudinal studies correlating early-life activity with later brain health.
Main Results:
- Epidemiological data show greater physical activity is associated with lower dementia risk.
- Interventional studies demonstrate physical activity increases prefrontal and hippocampal brain volumes.
- Longitudinal studies confirm larger brain volumes in physically active individuals.
Conclusions:
- Physical activity demonstrates a consistent and robust association with brain regions affected by cognitive decline and AD.
- Exercise interventions show potential for reducing memory impairments.
- Further research is recommended to optimize physical activity strategies for brain health.
Related Concept Videos
01:01Neuroplasticity
Neuroplasticity reflects the brain's remarkable capacity to adapt and evolve, responding dynamically to learning, experiences, or injury by reorganizing its neural circuitry. This reorganization involves creating new neural connections and refining old ones through a series of biological processes that contribute to the brain's lifelong development and adaptability.
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:22Gut-Brain Axis
The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such as...